Ironwood Investment Counsel LLC lifted its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,856 shares of the pharmacy operator’s stock after purchasing an additional 1,026 shares during the quarter. Ironwood Investment Counsel LLC’s holdings in Walgreens Boots Alliance were worth $2,458,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc lifted its position in Walgreens Boots Alliance by 0.6% during the third quarter. Vanguard Group Inc now owns 70,634,071 shares of the pharmacy operator’s stock worth $5,149,224,000 after buying an additional 448,045 shares in the last quarter. BlackRock Inc. lifted its position in Walgreens Boots Alliance by 1.7% during the fourth quarter. BlackRock Inc. now owns 53,681,897 shares of the pharmacy operator’s stock worth $3,668,086,000 after buying an additional 895,469 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in Walgreens Boots Alliance by 12,422.1% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 34,807,507 shares of the pharmacy operator’s stock worth $509,000 after buying an additional 34,529,539 shares in the last quarter. Northern Trust Corp lifted its position in Walgreens Boots Alliance by 5.8% during the fourth quarter. Northern Trust Corp now owns 11,641,152 shares of the pharmacy operator’s stock worth $795,439,000 after buying an additional 641,721 shares in the last quarter. Finally, LSV Asset Management raised its position in Walgreens Boots Alliance by 3.4% in the fourth quarter. LSV Asset Management now owns 11,564,931 shares of the pharmacy operator’s stock valued at $790,231,000 after purchasing an additional 381,017 shares during the period. Hedge funds and other institutional investors own 61.62% of the company’s stock.
Shares of NASDAQ:WBA traded down $0.56 on Wednesday, hitting $51.13. 3,543,707 shares of the company’s stock were exchanged, compared to its average volume of 6,457,458. The stock has a market cap of $47.33 billion, a P/E ratio of 8.49, a P/E/G ratio of 1.05 and a beta of 0.77. Walgreens Boots Alliance Inc has a 1-year low of $50.79 and a 1-year high of $86.31. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.38 and a current ratio of 0.78.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.70 by ($0.06). The business had revenue of $34.53 billion for the quarter, compared to analyst estimates of $34.57 billion. Walgreens Boots Alliance had a return on equity of 22.00% and a net margin of 3.77%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company posted $1.73 earnings per share. On average, equities research analysts predict that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Monday, May 20th will be given a $0.44 dividend. The ex-dividend date is Friday, May 17th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.44%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.
WBA has been the topic of a number of research analyst reports. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Saturday, April 13th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Monday, March 4th. Bank of America restated an “underperform” rating and issued a $62.00 target price (down previously from $69.00) on shares of Walgreens Boots Alliance in a research report on Friday, March 8th. Loop Capital cut their price objective on Walgreens Boots Alliance to $77.00 and set a “buy” rating on the stock in a report on Wednesday, March 27th. They noted that the move was a valuation call. Finally, Citigroup cut their price objective on Walgreens Boots Alliance from $76.00 to $60.00 and set a “neutral” rating on the stock in a report on Wednesday, April 3rd. Five research analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $67.89.
In other news, COO Ornella Barra bought 18,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was purchased at an average cost of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now directly owns 26,425 shares in the company, valued at $1,441,748. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the sale, the chief accounting officer now directly owns 435,811 shares of the company’s stock, valued at $23,119,773.55. The disclosure for this sale can be found here. 15.73% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “Ironwood Investment Counsel LLC Raises Holdings in Walgreens Boots Alliance Inc (WBA)” was published by Sundance Herald and is the property of of Sundance Herald. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at https://sundanceherald.com/2019/05/29/ironwood-investment-counsel-llc-has-2-46-million-stake-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
See Also: Growth Stocks
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.